Cannell & Spears LLC Sells 2,446 Shares of HCA Healthcare, Inc. $HCA

Cannell & Spears LLC lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 5.7% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 40,292 shares of the company’s stock after selling 2,446 shares during the period. Cannell & Spears LLC’s holdings in HCA Healthcare were worth $19,068,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of HCA. Palisade Asset Management LLC purchased a new position in shares of HCA Healthcare in the 3rd quarter valued at $26,000. Ares Financial Consulting LLC acquired a new position in shares of HCA Healthcare during the fourth quarter valued at about $31,000. Cedar Mountain Advisors LLC acquired a new stake in shares of HCA Healthcare during the first quarter worth $33,000. MCF Advisors LLC raised its stake in HCA Healthcare by 213.0% in the 4th quarter. MCF Advisors LLC now owns 72 shares of the company’s stock worth $34,000 after acquiring an additional 49 shares during the last quarter. Finally, Basepoint Wealth LLC purchased a new stake in HCA Healthcare during the 4th quarter valued at about $35,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on HCA. Truist Financial set a $413.00 target price on HCA Healthcare in a report on Thursday, June 4th. Royal Bank Of Canada decreased their price objective on shares of HCA Healthcare from $534.00 to $435.00 and set an “outperform” rating for the company in a research note on Wednesday, July 15th. JPMorgan Chase & Co. cut their price objective on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 19th. Leerink Partners lowered their price target on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Finally, TD Cowen reduced their price objective on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Fourteen investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $483.45.

HCA Healthcare Price Performance

HCA opened at $382.28 on Friday. The stock has a market cap of $84.80 billion, a P/E ratio of 13.15, a P/E/G ratio of 1.27 and a beta of 1.12. The firm has a fifty day moving average price of $386.95 and a 200 day moving average price of $453.73. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same quarter in the prior year, the firm posted $6.84 earnings per share. The company’s revenue was up 8.7% compared to the same quarter last year. Equities analysts expect that HCA Healthcare, Inc. will post 29.19 EPS for the current year.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA beat Q2 earnings estimates, reporting $7.59 per share versus expectations around $7.56-$7.57, while revenue rose 8.7% year over year to $20.23 billion and also topped estimates. HCA Healthcare earnings report
• Positive Sentiment: Management cited strong admissions and higher revenue per admission as key drivers of the quarter, suggesting healthy demand trends across its hospital network. Zacks article on HCA Q2 results
• Neutral Sentiment: HCA said its updated guidance is consistent with its earlier preview, so the quarter appears to confirm previously signaled results rather than deliver a major surprise. BusinessWire Q2 results
• Negative Sentiment: The company trimmed parts of its 2026 outlook, pointing to higher expenses and weaker surgical volumes as headwinds that could limit margin expansion. Zacks guidance revision article
• Negative Sentiment: Separate investor-law-firm investigations into HCA may add some legal overhang, though these notices are not operational results. Pomerantz investor alert

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.